The Arab Company for Pharmaceutical Industries and Medical Accessories (ACDIMA) has revealed that it is currently holding negotiations with a number of companies to set up a pharmaceutical raw materials manufacturing plant by $27 million investment costs.
The representative of ACDIMA in Riyadh, reported Al-Watan newspaper, said that the companies currently involved in these talks are the Saudi Basic Industries Company (SABIC), the Arab Investment Company and the Saudi Pharmaceutical Industries and Medical Accessories Company (SPIMACO). ¯ (Albawaba-MEBG)
© 2001 Mena Report (www.menareport.com)
